53.35
-0.91(-1.68%)
Currency In USD
| Previous Close | 54.26 |
| Open | 53.69 |
| Day High | 54.56 |
| Day Low | 53.01 |
| 52-Week High | 70.81 |
| 52-Week Low | 52 |
| Volume | 947,872 |
| Average Volume | 248,692 |
| Market Cap | 1.12B |
| PE | -113.51 |
| EPS | -0.47 |
| Moving Average 50 Days | 57.85 |
| Moving Average 200 Days | 61.87 |
| Change | -0.91 |
If you invested $1000 in ANI Pharmaceuticals, Inc. (ANIP) 10 years ago, it would be worth $955.75 as of December 22, 2024 at a share price of $53.35. Whereas If you bought $1000 worth of ANI Pharmaceuticals, Inc. (ANIP) shares 5 years ago, it would be worth $835.68 as of December 22, 2024 at a share price of $53.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
GlobeNewswire Inc.
Nov 26, 2024 9:30 PM GMT
PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host a
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
GlobeNewswire Inc.
Nov 08, 2024 11:50 AM GMT
Generated record quarterly net revenues of $148.3 million, representing year-over-year growth of 12.5%, and record Purified Cortrophin® Gel net revenues of $52.6 million, an increase of 76.8% year-over-yearNet loss of $(24.2) million and adjusted non
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
GlobeNewswire Inc.
Nov 04, 2024 9:30 PM GMT
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will presen